`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`MILTENYI BIOMEDICINE GmbH and MILTENYI BIOTEC INC.
`
`Petitioners
`
`
`
`v.
`
`
`
`THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA,
`
`Patent Owner
`
`
`
`
`
`Case IPR2022-00853
`
`U.S. Patent No. 9,464,140
`
`
`
`
`
`MANDATORY NOTICES BY PATENT OWNER
`
`
`
`
`
`
`
`39973967.1
`
`
`
`
`
`
`
`
`
`
`
`IPR2022-00853
`U.S. Patent No. 9,464,140
`
`Patent Owner, The Trustees of the University of Pennsylvania, submits the
`
`following mandatory notice.
`
`I. REAL PARTY-IN-INTEREST
`
`
`
`The real parties-in-interest are:
`
` the patent owner, The Trustees of the University of Pennsylvania; and
`
` the patent owner’s licensee, Novartis Pharma AG (“Novartis”).
`
`II. RELATED MATTERS
`
`
`
`A. District Court Litigation
`
`Patent Owner is not aware of any district court litigations that may affect, or
`
`be affected by, a decision in this proceeding.
`
`B.
`
`Patent Trial and Appeal Board
`
`
`
`U.S. Patent No. 9,464,140 (“the ‘140 Patent”) is not subject to any other
`
`inter partes review (“IPR”) proceedings.
`
`The following IPR proceeding(s) involve a patent related to the ‘140 Patent
`
`and may affect, or be affected by, a decision in this proceeding:
`
` Miltenyi Biomedicine GmbH & Miltenyi Biotec Inc. v. The Trustees of the
`
`University of Pennsylvania, IPR2022-00852, filed April 12, 2022
`
` Miltenyi Biomedicine GmbH & Miltenyi Biotec Inc. v. The Trustees of the
`
`University of Pennsylvania, IPR2022-00855, filed April 12, 2022
`
`
`
`
`39973967.1
`
`
`
`- 2 -
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2022-00853
`U.S. Patent No. 9,464,140
`
`C. United States Patent and Trademark Office
`
`The following pending U.S. patent application(s) may affect, or be affected
`
`by, a decision in this proceeding:
`
` U.S. Patent Application Serial No. 17/500,737, filed October 13, 2021.
`
`III. LEAD AND BACKUP COUNSEL
`
`Lead Counsel
`Brian R. Landry
`Reg. No. 62,074
`SAUL EWING ARNSTEIN & LEHR
`LLP
`131 Dartmouth Street, Suite 501
`Boston, MA 02116
`Tel: (617) 912-0969
`brian.landry@saul.com
`
`Backup Counsel
`Kathryn Doyle
`Reg. No. 36,317
`SAUL EWING ARNSTEIN & LEHR
`LLP
`Centre Square West
`1500 Market Street, 38th Floor
`Philadelphia, PA 19102
`Tel: (215)972-7734
`kathryn.doyle@saul.com
`
`
`
`
`
`
`
`Alireza Behrooz
`Reg. No. 60,882
`SAUL EWING ARNSTEIN & LEHR
`LLP
`1919 Pennsylvania Avenue, N.W.,
`Suite 550
`Washington, DC 20006-3434
`Tel: (202) 295-6687
`alireza.behrooz@saul.com
`
`
`
`
`39973967.1
`
`- 3 -
`
`
`
`
`
`
`
`
`
`
`IPR2022-00853
`U.S. Patent No. 9,464,140
`
`Additional Back-Up Counsel for Real Party in Interest and Licensee Novartis
`Thomas S. Fletcher
`Jessamyn S. Berniker
`Reg. No. 72,383
`Reg. No. 72,328
`WILLIAMS & CONNOLLY LLP
`WILLIAMS & CONNOLLY LLP
`680 Maine Avenue SW
`680 Maine Avenue SW
`Washington, DC 20024
`Washington, DC 20024
`Phone: 202-434-5497
`Phone: 202-434-5474
`Fax: 202-434-5029
`Fax: 202-434-5029
`tfletcher@wc.com
`jberniker@wc.com
`
`
`David M. Horniak
`David M. Krinsky
`Pro hac vice motion forthcoming
`Reg. No. 72,339
`WILLIAMS & CONNOLLY LLP
`WILLIAMS & CONNOLLY LLP
`680 Maine Avenue SW
`680 Maine Avenue SW
`Washington, DC 20024
`Washington, DC 20024
`Phone: 202-434-5852
`Phone: 202-434-5338
`Fax: 202-434-5029
`Fax: 202-434-5029
`dhorniak@wc.com
`dkrinsky@wc.com
`
`
`
`Kathryn S. Kayali
`Pro hac vice motion forthcoming
`WILLIAMS & CONNOLLY LLP
`680 Maine Avenue SW
`Washington, DC 20024
`Phone: 202-434-5644
`Fax: 202-434-5029
`kkayali@wc.com
`
`
`
`
`In accordance with 37 C.F.R. § 42.10(b), a power of attorney is not required
`
`for Patent Owner’s Counsel (Landry, Doyle, & Behrooz) because the designated
`
`counsel are already counsel of record in the subject patent. A power of attorney
`
`from Real Party in Interest and Licensee Novartis to Additional Back-Up Counsel
`
`for Real Party in Interest and Licensee Novartis is submitted herewith
`
`
`
`39973967.1
`
`- 4 -
`
`
`
`
`
`
`IV. SERVICE INFORMATION
`
`
`
`
`IPR2022-00853
`U.S. Patent No. 9,464,140
`
`Patent Owner consents to electronic service of all documents at the below
`
`email addresses:
`
` brian.landry@saul.com
`
` tfletcher@wc.com
`
` kathryn.doyle@saul.com
`
` NovartisCART@wc.com
`
` alireza.behrooz@saul.com
`
`
`
` IPGroupMailbox@saul.com
`
`Dated: May 2, 2022
`
`
`
`Respectfully submitted
`
`
`
`By:
`
`
`
`/Brian R. Landry/
`Brian Landry (Reg. No. 62,074)
`SAUL EWING ARNSTEIN & LEHR
`LLP
`131 Dartmouth Street, Suite 501
`Boston, MA 02116
`Tel: (617) 912-0969
`brian.landry@saul.com
`
`Counsel for Patent Owner
`
`
`
`
`
`
`
`
`39973967.1
`
`- 5 -
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2022-00853
`U.S. Patent No. 9,464,140
`
`Certification of Service Under 37 C.F.R. § 42.6(e)(4)
`
`The undersigned hereby certifies that on May 2, 2022, I caused a true and
`
`correct copy of the foregoing to be served on the following counsel for Petitioner
`
`by electronic mail to the following email addresses:
`
`Yite Jon Lu
`
`Gary Frischling
`
`
`
`
`
`jlu@milbank.com
`
`gfrischling@milbank.com
`
`
`
`39973967.1
`
`- 6 -
`
`